UK Markets closed

Hikma Pharmaceuticals PLC (HKMPY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
31.00+0.20 (+0.65%)
At close: 03:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.06
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 369.82
52-week low 325.12
50-day moving average 334.14
200-day moving average 346.28

Share statistics

Avg vol (3-month) 31.95k
Avg vol (10-day) 33.12k
Shares outstanding 5115.74M
Implied shares outstanding 6N/A
Float 880.94M
% held by insiders 10.00%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.08
Forward annual dividend yield 42.60%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 31.62%
5-year average dividend yield 41.73
Payout ratio 428.78%
Dividend date 329 Sept 2022
Ex-dividend date 416 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 16.49%
Operating margin (ttm)21.97%

Management effectiveness

Return on assets (ttm)8.24%
Return on equity (ttm)18.20%

Income statement

Revenue (ttm)2.55B
Revenue per share (ttm)22.10
Quarterly revenue growth (yoy)10.60%
Gross profit (ttm)1.3B
EBITDA 718M
Net income avi to common (ttm)421M
Diluted EPS (ttm)3.62
Quarterly earnings growth (yoy)-21.00%

Balance sheet

Total cash (mrq)450M
Total cash per share (mrq)3.89
Total debt (mrq)846M
Total debt/equity (mrq)34.29
Current ratio (mrq)2.06
Book value per share (mrq)18.53

Cash flow statement

Operating cash flow (ttm)638M
Levered free cash flow (ttm)269.75M